Sign up
Log in
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • NuCana (NASDAQ:NCNA) stock moved upwards by 106.2% to $0.95 during Monday's pre-market session. The company's market cap stands at $5.7 million.
  • INVO Fertility (NASDAQ:IVF) stock rose 22.22% to $2.2. The company's market cap stands at $10.8 million.
  • Firefly Neuroscience (NASDAQ:AIFF) shares rose 15.63% to $3.78. The company's market cap stands at $30.5 million.
  • BioCryst Pharma (NASDAQ:BCRX) shares rose 14.89% to $10.26. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q1 earnings report came out today.
  • iBio (NASDAQ:IBIO) stock moved upwards by 14.88% to $1.16. The company's market cap stands at $11.4 million. The company's, Q3 earnings came out yesterday.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 11.31% to $6.79. The market value of their outstanding shares is at $139.7 million.

Losers

  • Pliant Therapeutics (NASDAQ:PLRX) stock declined by 89.9% to $1.7 during Monday's pre-market session. The company's market cap stands at $104.5 million.
  • Impact BioMedical (AMEX:IBO) stock decreased by 21.53% to $0.59. The market value of their outstanding shares is at $6.7 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares fell 21.32% to $0.4. The market value of their outstanding shares is at $9.4 million.
  • Nexalin Technology (NASDAQ:NXL) shares fell 16.21% to $1.5. The market value of their outstanding shares is at $19.9 million.
  • ModivCare (NASDAQ:MODV) stock decreased by 14.39% to $1.25. The market value of their outstanding shares is at $17.9 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares declined by 14.09% to $0.43. The company's market cap stands at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.